Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Current Leases (2023 - 2025)

Maravai Lifesciences Holdings (MRVI) has 3 years of Current Leases data on record, last reported at $834000.0 in Q1 2025.

  • For Q1 2025, Current Leases rose 24.11% year-over-year to $834000.0; the TTM value through Mar 2025 reached $834000.0, up 24.11%, while the annual FY2024 figure was $792000.0, 25.12% up from the prior year.
  • Current Leases reached $834000.0 in Q1 2025 per MRVI's latest filing, up from $792000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $834000.0 in Q1 2025 and bottomed at $633000.0 in Q4 2023.
  • Average Current Leases over 3 years is $731833.3, with a median of $730000.0 recorded in 2024.
  • Peak YoY movement for Current Leases: rose 25.12% in 2024, then grew 24.11% in 2025.
  • A 3-year view of Current Leases shows it stood at $633000.0 in 2023, then grew by 25.12% to $792000.0 in 2024, then rose by 5.3% to $834000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $834000.0 in Q1 2025, $792000.0 in Q4 2024, and $750000.0 in Q3 2024.